Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
Targeted GAS6 Delivery to the CNS Protects Axons from Damage during Experimental Autoimmune Encephalomyelitis.
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Quantitative assessment of finger motor impairment in multiple sclerosis.
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
[Optic neuritis after influenza vaccination in a patient after stem cell transplantation].
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder.
Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.
Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Is There Extra Cost of Institutional Care for MS Patients?
Acute inflammation alters adult hippocampal neurogenesis in a multiple sclerosis mouse model.
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level: Commentary.
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia.
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.
Walking and cognition, but not symptoms, correlate with dual task cost of walking in multiple sclerosis.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares.

Pages